n,n-dimethylarginine has been researched along with n-acetylsphingosine in 1 studies
Studies (n,n-dimethylarginine) | Trials (n,n-dimethylarginine) | Recent Studies (post-2010) (n,n-dimethylarginine) | Studies (n-acetylsphingosine) | Trials (n-acetylsphingosine) | Recent Studies (post-2010) (n-acetylsphingosine) |
---|---|---|---|---|---|
2,216 | 228 | 1,221 | 506 | 0 | 64 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jia, W; Jiang, Q; Li, H; Qiu, Y; Sun, X; Xie, G; Zhao, A; Zheng, X; Zhong, W; Zhou, Y; Zhou, Z | 1 |
1 other study(ies) available for n,n-dimethylarginine and n-acetylsphingosine
Article | Year |
---|---|
Asymmetric dimethylarginine attenuates serum starvation-induced apoptosis via suppression of the Fas (APO-1/CD95)/JNK (SAPK) pathway.
Topics: Aged; Antibodies, Monoclonal; Apoptosis; Arginine; Case-Control Studies; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Culture Media, Serum-Free; Doxorubicin; Enzyme Activation; fas Receptor; Female; Fibroblasts; Humans; JNK Mitogen-Activated Protein Kinases; Male; Middle Aged; Signal Transduction; Sphingosine | 2013 |